Stryker Receives FDA Clearance for Incompass Total Ankle System Integrating Dual Platform Technologies
Key Insights
Stryker has received FDA 510(k) clearance for the Incompass Total Ankle System (search), designed for patients with ankle joints damaged by severe rheumatoid, post-traumatic, or degenerative arthritis (search).
The new platform integrates technologies from Stryker's Inbone and Infinity systems into a single comprehensive solution for total ankle replacement procedures.
The system incorporates data from more than 85,000 CT scans and 100,000 clinical cases to support patient-specific care and surgical efficiency.
Stryker announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Incompass Total Ankle System (search), an implant intended for patients with ankle joints damaged by severe rheumatoid, post-traumatic, or degenerative arthritis (search). The new platform integrates the innovative technologies of Stryker's Inbone and Infinity systems into a single, comprehensive solution for total ankle replacement.
Data-Driven Development and Clinical Foundation
The Incompass system represents a significant advancement in total ankle replacement technology, informed by extensive clinical data from more than 85,000 CT scans and 100,000 clinical cases. This data-driven approach aims to address key challenges in total ankle replacement, including intraoperative adaptability and procedural efficiency.
"Incompass reflects our commitment to redefining what's possible in total ankle replacement," said Adam Jacobs, vice president and general manager of Stryker's Foot & Ankle business. "By building on decades of clinical experience and leveraging extensive data insights, we're setting a new standard—one that empowers surgeons to deliver more personalized care with greater efficiency and confidence."
Advanced Technology Integration
The system incorporates Adaptis Boney Ingrowth Technology and redesigned instrumentation to support long-term fixation, surgical flexibility and streamlined workflow. Built using the Stryker Orthopaedic Modeling & Analytics (SOMA) platform in combination with arthritic ankle scans from the company's Prophecy Surgical Planning System, Incompass provides a continuum of implant and instrument options designed to accommodate both surgeon preference and patient anatomy.
Enhanced Surgical Features
System enhancements include a redesigned alignment system for greater control across multiple planes, updated implant holders and trial tools for improved handling, and instrumentation refinements designed to reduce surgical steps and set up time. The platform offers a broad range of implant and instrumentation options to support patient-specific care.
Clinical Impact
The Incompass Total Ankle System (search) is designed to streamline total ankle replacement procedures while providing surgeons with enhanced flexibility and precision. The integration of dual platform technologies into a single system represents Stryker's effort to address the complex needs of patients requiring ankle joint replacement due to severe arthritic conditions.